乗り物酔い治療の世界市場規模、シェア、産業動向分析レポート：薬剤クラス別（抗ヒスタミン薬、抗コリン薬、その他）、投与経路別、流通チャネル別、地域別展望と予測、2023～2029年

乗り物酔い治療市場規模は、2029年には4億8,100万米ドルに達すると予測され、予測期間中に3.2％のCAGRで成長すると予測されています。

乗り物酔いは予期せず起こることがあります。体温の急激な低下による発汗など、事前の予告なく症状が現れることがあります。めまい、疲労感、頭痛、イライラ、集中力の低下などがあります。また、胃腸の調子が悪くなる可能性や顔色が悪くなることもあります。呼吸困難の症状には、呼吸促迫やしゃくりあげるような呼吸が含まれることがあります。

COVID-19影響度分析

COVID-19の流行期には、世界中のツアーや旅行の数が減少し、それに伴い乗り物酔い治療薬の売り上げも減少しました。その結果、乗り物酔い治療市場は大きなダメージを受けました。また、パンデミックにより、世界中のほとんどの産業部門において生産活動の停止または中断が発生しました。このことは、乗り物酔い治療薬の生産にもある程度影響を与えました。ヘルスケア業界では、COVID-19パンデミックによりワークフローに混乱が生じました。

市場成長要因

観光産業の増加

旅行・観光産業は、航空券の低価格化、遠隔地や美しい観光地へのアクセス向上、可処分所得の急増などにより、増加しています。旅行・観光産業は、交通機関やインフラの大幅な発達によって強化されています。ミレニアル世代の旅行者の間では、個性的で特別な体験を求める声が高まっており、また、エコツーリズムは現在のシナリオにおいて成長傾向にあります。国内外からの観光客は、世界のほぼすべての地域で増加しており、個人は目的地に到着するために飛行機、車、船などさまざまな種類の交通機関を利用しています。しかし、これらの交通手段は多くの旅行者の乗り物酔いを引き起こし、治療が必要となる可能性があるため、市場の成長を促進することになります。

成長する製薬部門が乗り物酔い治療薬の充実を図る

医薬品業界は、革新的な技術の導入や、費用対効果に優れ効率的な製造プロセスの合理化により、大きな変化を経験しています。さらに、この分野での投資フローの増加は、分野の成長にプラスの影響を与えています。ロボット技術とAIを統合することで、製造現場のダウンタイムが減少し、製品の無駄を最小限に抑えることができます。製薬部門の開拓とその技術的進歩は、より効率的で費用対効果の高い乗り物酔い治療薬を提供し、それによってその採用を拡大し、乗り物酔い治療市場成長を促進すると予想されます。

市場抑制要因

乗り物酔い治療薬に関連する副作用

宇宙飛行士などの特定の職業では、認知機能、記憶、精神運動能力、眠気、疲労、めまいなどに影響を与える副作用があるため、H1-抗ヒスタミン薬の使用が制限されています。さらに、ジストニア、ジスキネジア、落ち着きのなさ、見当識障害、妄想、心臓への潜在的な害が報告されています。さらに、第一世代抗ヒスタミン薬の抗コリン作用は、口渇、目のかすみ、瞳孔散大、尿閉などの副作用をもたらすことがありますが、これらに限定されません。したがって、乗り物酔いの治療薬として最も著名な2つの薬物クラスである抗ヒスタミン薬と抗コリン薬の副作用は、これらの治療法の採用を減少させ、それによって乗り物酔い治療市場の成長を阻害する可能性があります。

薬物クラスの展望

乗り物酔い治療市場は、薬物クラスに基づき、抗ヒスタミン薬、抗コリン薬、その他に区分されます。抗ヒスタミン薬セグメントは、2022年に最大の収益シェアを獲得し、乗り物酔い治療市場を独占しました。これは、抗ヒスタミン薬が乗り物酔いを軽減するための費用対効果が高く、すぐに利用できる解決策であるためです。これは、旅行者の間で乗り物酔いの有病率が上昇していることに起因しています。さらに、乗り物酔いの予防と治療のために抗ヒスタミン薬を提供する大手企業の存在も、このセグメントの成長を後押ししています。

投与経路の展望

乗り物酔い治療市場は、投与経路によって経口薬とそれ以外の薬に分けられます。2022年の乗り物酔い治療市場において、経口薬以外のセグメントはかなりの収益シェアを調達しました。この背景には、乗り物酔いの治療や予防のための経皮パッチの利用が増加していることが挙げられます。また、これらの経皮パッチは、従来の薬と比較して、使いやすさ、コントロールドリリースメカニズム、効能の拡大といった利点があります。

流通チャネル別の展望

流通チャネル別に見ると、乗り物酔い治療市場は、ドラッグストアや小売薬局、オンライン薬局、病院薬局に分類されます。ドラッグストアや小売薬局セグメントは、2022年の乗り物酔い治療市場において最大の収益シェアを獲得しました。これは、薬局やドラッグストアが消費者に乗り物酔い治療薬を流通させる従来の手段であったためです。これらの施設では、これらの製品を割引価格で提供しています。ドラッグストアや小売薬局は、多くの人々の間で乗り物酔い治療薬の購入に好んで選ばれています。

地域別展望

乗り物酔い治療市場は、北米、欧州、アジア太平洋、LAMEA(ラテンアメリカ・中東・アフリカ)の各地域で分析されています。北米地域は、2022年に乗り物酔い治療市場で最も高い収益シェアを獲得しました。北米がヘルスケア産業において支配的な地位を占めているのは、充実したヘルスケアインフラと、高品質なヘルスケアに対する政府のバックアップに起因しています。その結果、北米には、一流の乗り物酔い治療薬を提供する有名な市場関係者が数多く存在します。

当レポートでは、市場の主要な利害関係者の分析について取り上げています。当レポートで紹介する主要企業は、Viatris, Inc.、Teva Pharmaceutical Industries Ltd.、Amneal Pharmaceuticals, Inc.、Baxter International, Inc.、Novartis AG、Abbott Laboratories、Sun Pharmaceutical Industries Ltd.、Zydus Lifesciences Ltd.、Prestige Consumer Healthcare, Inc., WellSpring Pharmaceutical Corporation（Avista Capital Partners）です。

目次

第1章 市場範囲と調査手法

• 市場の定義
• 目的
• 市場範囲
• セグメンテーション
  • 世界の乗り物酔い治療市場：薬剤クラス別
  • 世界の乗り物酔い治療市場：投与経路別
  • 世界の乗り物酔い治療市場：流通チャネル別
  • 世界の乗り物酔い治療市場：地域別
• 調査手法

第2章 市場概要

• イントロダクション
  • 概要
    • 市場構成とシナリオ
• 市場に影響を与える主な要因
  • 市場促進要因
  • 市場抑制要因

第3章 世界の乗り物酔い治療市場：薬剤クラス別

• 世界の抗ヒスタミン薬市場：地域別
• 世界の抗コリン薬市場：地域別
• 世界のその他の市場：地域別

第4章 世界の乗り物酔い治療市場：投与経路別

• 世界の経口薬市場：地域別
• 世界のその他の市場：地域別

第5章 世界の乗り物酔い治療市場：流通チャネル別

• 世界のドラッグストアおよび小売薬局市場：地域別
• 世界の病院薬局市場：地域別
• 世界のオンライン薬局市場：地域別

第6章 世界の乗り物酔い治療市場：地域別

• 北米
  • 北米の市場：国別
    • 米国
    • カナダ
    • メキシコ
    • その他北米地域
• 欧州
  • 欧州の市場：国別
    • ドイツ
    • 英国
    • フランス
    • ロシア
    • スペイン
    • イタリア
    • その他欧州地域
• アジア太平洋
  • アジア太平洋の市場：国別
    • 中国
    • 日本
    • インド
    • 韓国
    • シンガポール
    • マレーシア
    • その他アジア太平洋地域
• LAMEA（ラテンアメリカ・中東・アフリカ）
  • LAMEAの市場：国別
    • ブラジル
    • アルゼンチン
    • アラブ首長国連邦
    • サウジアラビア
    • 南アフリカ
    • ナイジェリア
    • LAMEAのその他地域

第7章 企業プロファイル

• Viatris, Inc
• Teva Pharmaceutical Industries Ltd
• Amneal Pharmaceuticals, Inc
• Baxter International, Inc
• Novartis AG
• Abbott Laboratories
• Sun Pharmaceutical Industries Ltd
• Zydus Lifesciences Ltd
• Prestige Consumer Healthcare, Inc
• WellSpring Pharmaceutical Corporation（Avista Capital Partners）

LIST OF TABLES

• TABLE 1 Global Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 2 Global Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 3 Global Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 4 Global Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 5 Global Antihistamines Market by Region, 2019 - 2022, USD Million
• TABLE 6 Global Antihistamines Market by Region, 2023 - 2029, USD Million
• TABLE 7 Global Anticholinergics Market by Region, 2019 - 2022, USD Million
• TABLE 8 Global Anticholinergics Market by Region, 2023 - 2029, USD Million
• TABLE 9 Global Others Market by Region, 2019 - 2022, USD Million
• TABLE 10 Global Others Market by Region, 2023 - 2029, USD Million
• TABLE 11 Global Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 12 Global Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 13 Global Oral Market by Region, 2019 - 2022, USD Million
• TABLE 14 Global Oral Market by Region, 2023 - 2029, USD Million
• TABLE 15 Global Others Market by Region, 2019 - 2022, USD Million
• TABLE 16 Global Others Market by Region, 2023 - 2029, USD Million
• TABLE 17 Global Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 18 Global Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 19 Global Drug Store & Retail Pharmacies Market by Region, 2019 - 2022, USD Million
• TABLE 20 Global Drug Store & Retail Pharmacies Market by Region, 2023 - 2029, USD Million
• TABLE 21 Global Hospital Pharmacies Market by Region, 2019 - 2022, USD Million
• TABLE 22 Global Hospital Pharmacies Market by Region, 2023 - 2029, USD Million
• TABLE 23 Global Online Pharmacies Market by Region, 2019 - 2022, USD Million
• TABLE 24 Global Online Pharmacies Market by Region, 2023 - 2029, USD Million
• TABLE 25 Global Motion Sickness Treatment Market by Region, 2019 - 2022, USD Million
• TABLE 26 Global Motion Sickness Treatment Market by Region, 2023 - 2029, USD Million
• TABLE 27 North America Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 28 North America Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 29 North America Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 30 North America Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 31 North America Antihistamines Market by Country, 2019 - 2022, USD Million
• TABLE 32 North America Antihistamines Market by Country, 2023 - 2029, USD Million
• TABLE 33 North America Anticholinergics Market by Country, 2019 - 2022, USD Million
• TABLE 34 North America Anticholinergics Market by Country, 2023 - 2029, USD Million
• TABLE 35 North America Others Market by Country, 2019 - 2022, USD Million
• TABLE 36 North America Others Market by Country, 2023 - 2029, USD Million
• TABLE 37 North America Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 38 North America Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 39 North America Oral Market by Country, 2019 - 2022, USD Million
• TABLE 40 North America Oral Market by Country, 2023 - 2029, USD Million
• TABLE 41 North America Others Market by Country, 2019 - 2022, USD Million
• TABLE 42 North America Others Market by Country, 2023 - 2029, USD Million
• TABLE 43 North America Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 44 North America Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 45 North America Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 46 North America Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 47 North America Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 48 North America Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 49 North America Online Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 50 North America Online Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 51 North America Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
• TABLE 52 North America Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
• TABLE 53 US Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 54 US Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 55 US Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 56 US Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 57 US Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 58 US Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 59 US Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 60 US Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 61 Canada Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 62 Canada Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 63 Canada Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 64 Canada Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 65 Canada Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 66 Canada Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 67 Canada Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 68 Canada Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 69 Mexico Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 70 Mexico Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 71 Mexico Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 72 Mexico Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 73 Mexico Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 74 Mexico Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 75 Mexico Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 76 Mexico Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 77 Rest of North America Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 78 Rest of North America Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 79 Rest of North America Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 80 Rest of North America Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 81 Rest of North America Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 82 Rest of North America Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 83 Rest of North America Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 84 Rest of North America Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 85 Europe Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 86 Europe Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 87 Europe Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 88 Europe Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 89 Europe Antihistamines Market by Country, 2019 - 2022, USD Million
• TABLE 90 Europe Antihistamines Market by Country, 2023 - 2029, USD Million
• TABLE 91 Europe Anticholinergics Market by Country, 2019 - 2022, USD Million
• TABLE 92 Europe Anticholinergics Market by Country, 2023 - 2029, USD Million
• TABLE 93 Europe Others Market by Country, 2019 - 2022, USD Million
• TABLE 94 Europe Others Market by Country, 2023 - 2029, USD Million
• TABLE 95 Europe Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 96 Europe Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 97 Europe Oral Market by Country, 2019 - 2022, USD Million
• TABLE 98 Europe Oral Market by Country, 2023 - 2029, USD Million
• TABLE 99 Europe Others Market by Country, 2019 - 2022, USD Million
• TABLE 100 Europe Others Market by Country, 2023 - 2029, USD Million
• TABLE 101 Europe Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 102 Europe Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 103 Europe Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 104 Europe Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 105 Europe Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 106 Europe Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 107 Europe Online Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 108 Europe Online Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 109 Europe Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
• TABLE 110 Europe Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
• TABLE 111 Germany Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 112 Germany Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 113 Germany Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 114 Germany Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 115 Germany Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 116 Germany Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 117 Germany Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 118 Germany Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 119 UK Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 120 UK Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 121 UK Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 122 UK Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 123 UK Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 124 UK Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 125 UK Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 126 UK Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 127 France Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 128 France Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 129 France Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 130 France Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 131 France Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 132 France Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 133 France Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 134 France Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 135 Russia Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 136 Russia Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 137 Russia Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 138 Russia Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 139 Russia Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 140 Russia Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 141 Russia Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 142 Russia Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 143 Spain Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 144 Spain Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 145 Spain Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 146 Spain Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 147 Spain Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 148 Spain Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 149 Spain Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 150 Spain Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 151 Italy Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 152 Italy Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 153 Italy Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 154 Italy Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 155 Italy Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 156 Italy Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 157 Italy Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 158 Italy Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 159 Rest of Europe Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 160 Rest of Europe Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 161 Rest of Europe Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 162 Rest of Europe Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 163 Rest of Europe Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 164 Rest of Europe Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 165 Rest of Europe Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 166 Rest of Europe Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 167 Asia Pacific Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 168 Asia Pacific Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 169 Asia Pacific Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 170 Asia Pacific Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 171 Asia Pacific Antihistamines Market by Country, 2019 - 2022, USD Million
• TABLE 172 Asia Pacific Antihistamines Market by Country, 2023 - 2029, USD Million
• TABLE 173 Asia Pacific Anticholinergics Market by Country, 2019 - 2022, USD Million
• TABLE 174 Asia Pacific Anticholinergics Market by Country, 2023 - 2029, USD Million
• TABLE 175 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
• TABLE 176 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
• TABLE 177 Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 178 Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 179 Asia Pacific Oral Market by Country, 2019 - 2022, USD Million
• TABLE 180 Asia Pacific Oral Market by Country, 2023 - 2029, USD Million
• TABLE 181 Asia Pacific Others Market by Country, 2019 - 2022, USD Million
• TABLE 182 Asia Pacific Others Market by Country, 2023 - 2029, USD Million
• TABLE 183 Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 184 Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 185 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 186 Asia Pacific Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 187 Asia Pacific Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 188 Asia Pacific Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 189 Asia Pacific Online Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 190 Asia Pacific Online Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 191 Asia Pacific Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
• TABLE 192 Asia Pacific Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
• TABLE 193 China Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 194 China Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 195 China Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 196 China Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 197 China Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 198 China Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 199 China Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 200 China Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 201 Japan Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 202 Japan Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 203 Japan Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 204 Japan Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 205 Japan Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 206 Japan Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 207 Japan Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 208 Japan Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 209 India Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 210 India Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 211 India Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 212 India Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 213 India Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 214 India Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 215 India Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 216 India Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 217 South Korea Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 218 South Korea Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 219 South Korea Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 220 South Korea Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 221 South Korea Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 222 South Korea Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 223 South Korea Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 224 South Korea Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 225 Singapore Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 226 Singapore Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 227 Singapore Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 228 Singapore Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 229 Singapore Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 230 Singapore Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 231 Singapore Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 232 Singapore Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 233 Malaysia Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 234 Malaysia Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 235 Malaysia Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 236 Malaysia Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 237 Malaysia Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 238 Malaysia Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 239 Malaysia Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 240 Malaysia Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 241 Rest of Asia Pacific Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 242 Rest of Asia Pacific Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 243 Rest of Asia Pacific Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 244 Rest of Asia Pacific Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 245 Rest of Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 246 Rest of Asia Pacific Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 247 Rest of Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 248 Rest of Asia Pacific Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 249 LAMEA Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 250 LAMEA Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 251 LAMEA Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 252 LAMEA Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 253 LAMEA Antihistamines Market by Country, 2019 - 2022, USD Million
• TABLE 254 LAMEA Antihistamines Market by Country, 2023 - 2029, USD Million
• TABLE 255 LAMEA Anticholinergics Market by Country, 2019 - 2022, USD Million
• TABLE 256 LAMEA Anticholinergics Market by Country, 2023 - 2029, USD Million
• TABLE 257 LAMEA Others Market by Country, 2019 - 2022, USD Million
• TABLE 258 LAMEA Others Market by Country, 2023 - 2029, USD Million
• TABLE 259 LAMEA Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 260 LAMEA Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 261 LAMEA Oral Market by Country, 2019 - 2022, USD Million
• TABLE 262 LAMEA Oral Market by Country, 2023 - 2029, USD Million
• TABLE 263 LAMEA Others Market by Country, 2019 - 2022, USD Million
• TABLE 264 LAMEA Others Market by Country, 2023 - 2029, USD Million
• TABLE 265 LAMEA Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 266 LAMEA Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 267 LAMEA Drug Store & Retail Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 268 LAMEA Drug Store & Retail Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 269 LAMEA Hospital Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 270 LAMEA Hospital Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 271 LAMEA Online Pharmacies Market by Country, 2019 - 2022, USD Million
• TABLE 272 LAMEA Online Pharmacies Market by Country, 2023 - 2029, USD Million
• TABLE 273 LAMEA Motion Sickness Treatment Market by Country, 2019 - 2022, USD Million
• TABLE 274 LAMEA Motion Sickness Treatment Market by Country, 2023 - 2029, USD Million
• TABLE 275 Brazil Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 276 Brazil Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 277 Brazil Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 278 Brazil Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 279 Brazil Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 280 Brazil Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 281 Brazil Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 282 Brazil Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 283 Argentina Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 284 Argentina Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 285 Argentina Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 286 Argentina Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 287 Argentina Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 288 Argentina Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 289 Argentina Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 290 Argentina Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 291 UAE Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 292 UAE Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 293 UAE Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 294 UAE Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 295 UAE Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 296 UAE Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 297 UAE Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 298 UAE Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million

• TABLE 299 Saudi Arabia Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 300 Saudi Arabia Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 301 Saudi Arabia Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 302 Saudi Arabia Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 303 Saudi Arabia Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 304 Saudi Arabia Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 305 Saudi Arabia Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 306 Saudi Arabia Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 307 South Africa Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 308 South Africa Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 309 South Africa Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 310 South Africa Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 311 South Africa Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 312 South Africa Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 313 South Africa Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 314 South Africa Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 315 Nigeria Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 316 Nigeria Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 317 Nigeria Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 318 Nigeria Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 319 Nigeria Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 320 Nigeria Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 321 Nigeria Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 322 Nigeria Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 323 Rest of LAMEA Motion Sickness Treatment Market, 2019 - 2022, USD Million
• TABLE 324 Rest of LAMEA Motion Sickness Treatment Market, 2023 - 2029, USD Million
• TABLE 325 Rest of LAMEA Motion Sickness Treatment Market by Drug Class, 2019 - 2022, USD Million
• TABLE 326 Rest of LAMEA Motion Sickness Treatment Market by Drug Class, 2023 - 2029, USD Million
• TABLE 327 Rest of LAMEA Motion Sickness Treatment Market by Route of Administration, 2019 - 2022, USD Million
• TABLE 328 Rest of LAMEA Motion Sickness Treatment Market by Route of Administration, 2023 - 2029, USD Million
• TABLE 329 Rest of LAMEA Motion Sickness Treatment Market by Distribution Channel, 2019 - 2022, USD Million
• TABLE 330 Rest of LAMEA Motion Sickness Treatment Market by Distribution Channel, 2023 - 2029, USD Million
• TABLE 331 key information - Viatris, Inc.
• TABLE 332 Key Information - Teva Pharmaceuticals Industries Ltd.
• TABLE 333 Key Information - Amneal Pharmaceuticals, INc.
• TABLE 334 Key Information - Baxter International, Inc.
• TABLE 335 Key Information - Novartis AG
• TABLE 336 Key Information - Abbott Laboratories
• TABLE 337 Key Information - Sun Pharmaceutical Industries Ltd.
• TABLE 338 Key Information - Zydus Lifesciences Ltd.
• TABLE 339 Key Information - Prestige consumer healthcare inc.
• TABLE 340 Key Information - WellSpring Pharmaceutical Corporation

List of Figures

• FIG 1 Methodology for the research
• FIG 2 Global Motion Sickness Treatment Market share by Drug Class, 2022
• FIG 3 Global Motion Sickness Treatment Market share by Drug Class, 2029
• FIG 4 Global Motion Sickness Treatment Market by Drug Class, 2019 - 2029, USD Million
• FIG 5 Global Motion Sickness Treatment Market share by Route of Administration, 2022
• FIG 6 Global Motion Sickness Treatment Market share by Route of Administration, 2029
• FIG 7 Global Motion Sickness Treatment Market by Route of Administration, 2019 - 2029, USD Million
• FIG 8 Global Motion Sickness Treatment Market share by Distribution Channel, 2022
• FIG 9 Global Motion Sickness Treatment Market share by Distribution Channel, 2029
• FIG 10 Global Motion Sickness Treatment Market by Distribution Channel, 2019 - 2029, USD Million
• FIG 11 Global Motion Sickness Treatment Market share by Region, 2022
• FIG 12 Global Motion Sickness Treatment Market share by Region, 2029
• FIG 13 Global Motion Sickness Treatment Market by Region, 2019 - 2029, USD Million
• FIG 14 Swot analysis: Abbott laboratories

The Global Motion Sickness Treatment Market size is expected to reach $481 Million by 2029, rising at a market growth of 3.2% CAGR during the forecast period.

Motion sickness is a condition that arises when the brain is unable to interpret the information received from the eyes, ears, and body. Frequent movement, whether in a vehicle, aircraft, watercraft, or a recreational attraction, can induce discomfort, perspiration, or nausea. Certain individuals experience nausea and may regurgitate. Motion sickness is a condition that occurs when traveling by car, sea, or air, causing discomfort and nausea.

When driving a vehicle, the visual senses perceive the surroundings and detect motion. The inner ears are responsible for detecting movement. The body's muscles and joints perceive a state of stillness while seated. The brain senses a lack of coherence between these messages, causing motion sickness. Various factors can induce motion sickness, including amusement park attractions and virtual reality simulations. Reading while in transit, using transportation options like boats, cars, buses, trains, and planes. Also, too much consumption of entertainment media such as movies and video games can lead to motion sickness.

Motion sickness may occur unexpectedly. Individuals may exhibit symptoms without prior warning, including perspiration caused by a sudden drop in body temperature. Dizziness, fatigue, headache, irritability, difficulty in maintaining focus. Symptoms of potential gastrointestinal distress. Fair complexion. Symptoms of respiratory distress may include rapid breathing or gasping for air.

COVID-19 Impact Analysis

During the COVID-19 pandemic, the number of tours and journeys throughout the world declined, which led to a subsequent drop in sales of motion sickness medication. As a result, the market for motion sickness therapy was significantly damaged. In addition, the pandemic was responsible for the shutdown or suspension of production operations in most industrial units around the world. This had an effect, to some degree, on the production of motion sickness treatments. The healthcare industry has experienced a disruption in workflows due to the COVID-19 pandemic.

Market Growth Factors

Rising Tourism Industry

The travel and tourism industry are increasing due to the increasing affordability of air travel, enhanced accessibility to remote and picturesque destinations, and a surge in disposable income. The travel and tourism sector has been strengthened by the substantial development of transportation facilities and infrastructure. There is a growing demand among millennial travelers for distinctive and exclusive experiences and also ecotourism is a growing trend in the current scenario. National and international tourism is increasing in almost all parts of the world, and individuals use various types of transportation to reach their destinations, like airplanes, cars, and ships. However, these modes of transportation can cause many travelers' motion sickness to kick in, which may require treatment and thereby propel the market growth.

Growing Pharma Sector to Provide Enhanced Motion Sickness Medications

The pharmaceutical industry has experienced significant changes due to the introduction of innovative technologies and streamlined manufacturing processes that are both cost-effective and efficient. Furthermore, the rise in investment flow within this sector has positively impacted sector growth. Integrating robotic technology and AI leads to decreased manufacturing floor downtime and minimizes product waste. The development of the pharma sector and its technological advancement is expected to provide more efficient and cost-effective medications for motion sickness and thereby increase their adoption, driving the market growth for motion sickness treatment.

Market Restraining Factors

Associated Side Effects of Motion Sickness Medication

H1-antihistamines in certain professions, such as astronauts, are limited due to side effects that can affect cognitive function, memory, psychomotor performance, drowsiness, fatigue, and dizziness. Additional documented negative outcomes comprise dystonia, dyskinesia, restlessness, disorientation, delusions, and potential harm to the heart. Furthermore, the anticholinergic activity of first-generation antihistamines may result in adverse effects, including but not limited to dry mouth, blurred vision, dilated pupils, and urinary retention. Hence, with the side effects of antihistamines and anticholinergics two most prominent drug classes for the treatment of motion sickness can decrease the adoption of these treatment options and, thereby, hamper the market growth of motion sickness treatment.

Drug Class Outlook

Based on drug class, the motion sickness treatment market is segmented into antihistamines, anticholinergics and others. The antihistamines segment dominated the motion sickness treatment market with maximum revenue share in 2022. This is because antihistamines are a cost-effective and readily available solution for reducing motion sickness. This is due to a rise in the prevalence of motion sickness among travelers. Furthermore, the segment's growth is being propelled by the presence of major players who provide antihistamine medications to prevent and treat motion sickness.

Route of Administration Outlook

On the basis of route of administration, the motion sickness treatment market is divided into oral and others. The others segment procured a substantial revenue share in the motion sickness treatment market in 2022. This is due to the rise in the usage of transdermal patches for motion sickness treatment and prevention, which is the reason behind this trend. In addition, these transdermal patches provide benefits such as user-friendliness, controlled release mechanism, and extended efficacy in comparison to traditional medications.

Distribution Channel Outlook

By distribution channel, the motion sickness treatment market is classified into drug store & retail pharmacies, online pharmacies and hospital pharmacies. The drug store & retail pharmacies segment witnessed the largest revenue share in the motion sickness treatment market in 2022. This is because pharmacies and drug stores have been the traditional means of distributing motion sickness medication to consumers. These establishments offer these products at discounted prices. Drug stores and retail pharmacies are the preferred choice for purchasing motion sickness medications among most of the population.

Regional Outlook

Region-wise, the motion sickness treatment market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region registered the highest revenue share in the motion sickness treatment market in 2022. North America's dominant position in the healthcare industry can be attributed to its robust healthcare infrastructure and government backing for high-quality healthcare. As a result, North America has a significant number of prominent market players who provide top-notch motion sickness medications.

The market research report covers the analysis of key stakeholders of the market. Key companies profiled in the report include Viatris, Inc., Teva Pharmaceutical Industries Ltd., Amneal Pharmaceuticals, Inc., Baxter International, Inc., Novartis AG, Abbott Laboratories, Sun Pharmaceutical Industries Ltd., Zydus Lifesciences Ltd., Prestige Consumer Healthcare, Inc., WellSpring Pharmaceutical Corporation (Avista Capital Partners)

Scope of the Study

Market Segments covered in the Report:

By Drug Class

• Antihistamines
• Anticholinergics
• Others

By Route of Administration

• Oral
• Others

By Distribution Channel

• Drug Store & Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Viatris, Inc.
• Teva Pharmaceutical Industries Ltd.
• Amneal Pharmaceuticals, Inc.
• Baxter International, Inc.
• Novartis AG
• Abbott Laboratories
• Sun Pharmaceutical Industries Ltd.
• Zydus Lifesciences Ltd.
• Prestige Consumer Healthcare, Inc.
• WellSpring Pharmaceutical Corporation (Avista Capital Partners)

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Motion Sickness Treatment Market, by Drug Class
  • 1.4.2 Global Motion Sickness Treatment Market, by Route of Administration
  • 1.4.3 Global Motion Sickness Treatment Market, by Distribution Channel
  • 1.4.4 Global Motion Sickness Treatment Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market Overview

• 2.1 Introduction
  • 2.1.1 Overview
    • 2.1.1.1 Market composition & scenario
• 2.2 Key Factors Impacting the Market
  • 2.2.1 Market Drivers
  • 2.2.2 Market Restraints

Chapter 3. Global Motion Sickness Treatment Market by Drug Class

• 3.1 Global Antihistamines Market by Region
• 3.2 Global Anticholinergics Market by Region
• 3.3 Global Others Market by Region

Chapter 4. Global Motion Sickness Treatment Market by Route of Administration

• 4.1 Global Oral Market by Region
• 4.2 Global Others Market by Region

Chapter 5. Global Motion Sickness Treatment Market by Distribution Channel

• 5.1 Global Drug Store & Retail Pharmacies Market by Region
• 5.2 Global Hospital Pharmacies Market by Region
• 5.3 Global Online Pharmacies Market by Region

Chapter 6. Global Motion Sickness Treatment Market by Region

• 6.1 North America Motion Sickness Treatment Market
  • 6.1.1 North America Motion Sickness Treatment Market by Drug Class
    • 6.1.1.1 North America Antihistamines Market by Country
    • 6.1.1.2 North America Anticholinergics Market by Country
    • 6.1.1.3 North America Others Market by Country
  • 6.1.2 North America Motion Sickness Treatment Market by Route of Administration
    • 6.1.2.1 North America Oral Market by Country
    • 6.1.2.2 North America Others Market by Country
  • 6.1.3 North America Motion Sickness Treatment Market by Distribution Channel
    • 6.1.3.1 North America Drug Store & Retail Pharmacies Market by Country
    • 6.1.3.2 North America Hospital Pharmacies Market by Country
    • 6.1.3.3 North America Online Pharmacies Market by Country
  • 6.1.4 North America Motion Sickness Treatment Market by Country
    • 6.1.4.1 US Motion Sickness Treatment Market
      • 6.1.4.1.1 US Motion Sickness Treatment Market by Drug Class
      • 6.1.4.1.2 US Motion Sickness Treatment Market by Route of Administration
      • 6.1.4.1.3 US Motion Sickness Treatment Market by Distribution Channel
    • 6.1.4.2 Canada Motion Sickness Treatment Market
      • 6.1.4.2.1 Canada Motion Sickness Treatment Market by Drug Class
      • 6.1.4.2.2 Canada Motion Sickness Treatment Market by Route of Administration
      • 6.1.4.2.3 Canada Motion Sickness Treatment Market by Distribution Channel
    • 6.1.4.3 Mexico Motion Sickness Treatment Market
      • 6.1.4.3.1 Mexico Motion Sickness Treatment Market by Drug Class
      • 6.1.4.3.2 Mexico Motion Sickness Treatment Market by Route of Administration
      • 6.1.4.3.3 Mexico Motion Sickness Treatment Market by Distribution Channel
    • 6.1.4.4 Rest of North America Motion Sickness Treatment Market
      • 6.1.4.4.1 Rest of North America Motion Sickness Treatment Market by Drug Class
      • 6.1.4.4.2 Rest of North America Motion Sickness Treatment Market by Route of Administration
      • 6.1.4.4.3 Rest of North America Motion Sickness Treatment Market by Distribution Channel
• 6.2 Europe Motion Sickness Treatment Market
  • 6.2.1 Europe Motion Sickness Treatment Market by Drug Class
    • 6.2.1.1 Europe Antihistamines Market by Country
    • 6.2.1.2 Europe Anticholinergics Market by Country
    • 6.2.1.3 Europe Others Market by Country
  • 6.2.2 Europe Motion Sickness Treatment Market by Route of Administration
    • 6.2.2.1 Europe Oral Market by Country
    • 6.2.2.2 Europe Others Market by Country
  • 6.2.3 Europe Motion Sickness Treatment Market by Distribution Channel
    • 6.2.3.1 Europe Drug Store & Retail Pharmacies Market by Country
    • 6.2.3.2 Europe Hospital Pharmacies Market by Country
    • 6.2.3.3 Europe Online Pharmacies Market by Country
  • 6.2.4 Europe Motion Sickness Treatment Market by Country
    • 6.2.4.1 Germany Motion Sickness Treatment Market
      • 6.2.4.1.1 Germany Motion Sickness Treatment Market by Drug Class
      • 6.2.4.1.2 Germany Motion Sickness Treatment Market by Route of Administration
      • 6.2.4.1.3 Germany Motion Sickness Treatment Market by Distribution Channel
    • 6.2.4.2 UK Motion Sickness Treatment Market
      • 6.2.4.2.1 UK Motion Sickness Treatment Market by Drug Class
      • 6.2.4.2.2 UK Motion Sickness Treatment Market by Route of Administration
      • 6.2.4.2.3 UK Motion Sickness Treatment Market by Distribution Channel
    • 6.2.4.3 France Motion Sickness Treatment Market
      • 6.2.4.3.1 France Motion Sickness Treatment Market by Drug Class
      • 6.2.4.3.2 France Motion Sickness Treatment Market by Route of Administration
      • 6.2.4.3.3 France Motion Sickness Treatment Market by Distribution Channel
    • 6.2.4.4 Russia Motion Sickness Treatment Market
      • 6.2.4.4.1 Russia Motion Sickness Treatment Market by Drug Class
      • 6.2.4.4.2 Russia Motion Sickness Treatment Market by Route of Administration
      • 6.2.4.4.3 Russia Motion Sickness Treatment Market by Distribution Channel
    • 6.2.4.5 Spain Motion Sickness Treatment Market
      • 6.2.4.5.1 Spain Motion Sickness Treatment Market by Drug Class
      • 6.2.4.5.2 Spain Motion Sickness Treatment Market by Route of Administration
      • 6.2.4.5.3 Spain Motion Sickness Treatment Market by Distribution Channel
    • 6.2.4.6 Italy Motion Sickness Treatment Market
      • 6.2.4.6.1 Italy Motion Sickness Treatment Market by Drug Class
      • 6.2.4.6.2 Italy Motion Sickness Treatment Market by Route of Administration
      • 6.2.4.6.3 Italy Motion Sickness Treatment Market by Distribution Channel
    • 6.2.4.7 Rest of Europe Motion Sickness Treatment Market
      • 6.2.4.7.1 Rest of Europe Motion Sickness Treatment Market by Drug Class
      • 6.2.4.7.2 Rest of Europe Motion Sickness Treatment Market by Route of Administration
      • 6.2.4.7.3 Rest of Europe Motion Sickness Treatment Market by Distribution Channel
• 6.3 Asia Pacific Motion Sickness Treatment Market
  • 6.3.1 Asia Pacific Motion Sickness Treatment Market by Drug Class
    • 6.3.1.1 Asia Pacific Antihistamines Market by Country
    • 6.3.1.2 Asia Pacific Anticholinergics Market by Country
    • 6.3.1.3 Asia Pacific Others Market by Country
  • 6.3.2 Asia Pacific Motion Sickness Treatment Market by Route of Administration
    • 6.3.2.1 Asia Pacific Oral Market by Country
    • 6.3.2.2 Asia Pacific Others Market by Country
  • 6.3.3 Asia Pacific Motion Sickness Treatment Market by Distribution Channel
    • 6.3.3.1 Asia Pacific Drug Store & Retail Pharmacies Market by Country
    • 6.3.3.2 Asia Pacific Hospital Pharmacies Market by Country
    • 6.3.3.3 Asia Pacific Online Pharmacies Market by Country
  • 6.3.4 Asia Pacific Motion Sickness Treatment Market by Country
    • 6.3.4.1 China Motion Sickness Treatment Market
      • 6.3.4.1.1 China Motion Sickness Treatment Market by Drug Class
      • 6.3.4.1.2 China Motion Sickness Treatment Market by Route of Administration
      • 6.3.4.1.3 China Motion Sickness Treatment Market by Distribution Channel
    • 6.3.4.2 Japan Motion Sickness Treatment Market
      • 6.3.4.2.1 Japan Motion Sickness Treatment Market by Drug Class
      • 6.3.4.2.2 Japan Motion Sickness Treatment Market by Route of Administration
      • 6.3.4.2.3 Japan Motion Sickness Treatment Market by Distribution Channel
    • 6.3.4.3 India Motion Sickness Treatment Market
      • 6.3.4.3.1 India Motion Sickness Treatment Market by Drug Class
      • 6.3.4.3.2 India Motion Sickness Treatment Market by Route of Administration
      • 6.3.4.3.3 India Motion Sickness Treatment Market by Distribution Channel
    • 6.3.4.4 South Korea Motion Sickness Treatment Market
      • 6.3.4.4.1 South Korea Motion Sickness Treatment Market by Drug Class
      • 6.3.4.4.2 South Korea Motion Sickness Treatment Market by Route of Administration
      • 6.3.4.4.3 South Korea Motion Sickness Treatment Market by Distribution Channel
    • 6.3.4.5 Singapore Motion Sickness Treatment Market
      • 6.3.4.5.1 Singapore Motion Sickness Treatment Market by Drug Class
      • 6.3.4.5.2 Singapore Motion Sickness Treatment Market by Route of Administration
      • 6.3.4.5.3 Singapore Motion Sickness Treatment Market by Distribution Channel
    • 6.3.4.6 Malaysia Motion Sickness Treatment Market
      • 6.3.4.6.1 Malaysia Motion Sickness Treatment Market by Drug Class
      • 6.3.4.6.2 Malaysia Motion Sickness Treatment Market by Route of Administration
      • 6.3.4.6.3 Malaysia Motion Sickness Treatment Market by Distribution Channel
    • 6.3.4.7 Rest of Asia Pacific Motion Sickness Treatment Market
      • 6.3.4.7.1 Rest of Asia Pacific Motion Sickness Treatment Market by Drug Class
      • 6.3.4.7.2 Rest of Asia Pacific Motion Sickness Treatment Market by Route of Administration
      • 6.3.4.7.3 Rest of Asia Pacific Motion Sickness Treatment Market by Distribution Channel
• 6.4 LAMEA Motion Sickness Treatment Market
  • 6.4.1 LAMEA Motion Sickness Treatment Market by Drug Class
    • 6.4.1.1 LAMEA Antihistamines Market by Country
    • 6.4.1.2 LAMEA Anticholinergics Market by Country
    • 6.4.1.3 LAMEA Others Market by Country
  • 6.4.2 LAMEA Motion Sickness Treatment Market by Route of Administration
    • 6.4.2.1 LAMEA Oral Market by Country
    • 6.4.2.2 LAMEA Others Market by Country
  • 6.4.3 LAMEA Motion Sickness Treatment Market by Distribution Channel
    • 6.4.3.1 LAMEA Drug Store & Retail Pharmacies Market by Country
    • 6.4.3.2 LAMEA Hospital Pharmacies Market by Country
    • 6.4.3.3 LAMEA Online Pharmacies Market by Country
  • 6.4.4 LAMEA Motion Sickness Treatment Market by Country
    • 6.4.4.1 Brazil Motion Sickness Treatment Market
      • 6.4.4.1.1 Brazil Motion Sickness Treatment Market by Drug Class
      • 6.4.4.1.2 Brazil Motion Sickness Treatment Market by Route of Administration
      • 6.4.4.1.3 Brazil Motion Sickness Treatment Market by Distribution Channel
    • 6.4.4.2 Argentina Motion Sickness Treatment Market
      • 6.4.4.2.1 Argentina Motion Sickness Treatment Market by Drug Class
      • 6.4.4.2.2 Argentina Motion Sickness Treatment Market by Route of Administration
      • 6.4.4.2.3 Argentina Motion Sickness Treatment Market by Distribution Channel
    • 6.4.4.3 UAE Motion Sickness Treatment Market
      • 6.4.4.3.1 UAE Motion Sickness Treatment Market by Drug Class
      • 6.4.4.3.2 UAE Motion Sickness Treatment Market by Route of Administration
      • 6.4.4.3.3 UAE Motion Sickness Treatment Market by Distribution Channel
    • 6.4.4.4 Saudi Arabia Motion Sickness Treatment Market
      • 6.4.4.4.1 Saudi Arabia Motion Sickness Treatment Market by Drug Class
      • 6.4.4.4.2 Saudi Arabia Motion Sickness Treatment Market by Route of Administration
      • 6.4.4.4.3 Saudi Arabia Motion Sickness Treatment Market by Distribution Channel
    • 6.4.4.5 South Africa Motion Sickness Treatment Market
      • 6.4.4.5.1 South Africa Motion Sickness Treatment Market by Drug Class
      • 6.4.4.5.2 South Africa Motion Sickness Treatment Market by Route of Administration
      • 6.4.4.5.3 South Africa Motion Sickness Treatment Market by Distribution Channel
    • 6.4.4.6 Nigeria Motion Sickness Treatment Market
      • 6.4.4.6.1 Nigeria Motion Sickness Treatment Market by Drug Class
      • 6.4.4.6.2 Nigeria Motion Sickness Treatment Market by Route of Administration
      • 6.4.4.6.3 Nigeria Motion Sickness Treatment Market by Distribution Channel
    • 6.4.4.7 Rest of LAMEA Motion Sickness Treatment Market
      • 6.4.4.7.1 Rest of LAMEA Motion Sickness Treatment Market by Drug Class
      • 6.4.4.7.2 Rest of LAMEA Motion Sickness Treatment Market by Route of Administration
      • 6.4.4.7.3 Rest of LAMEA Motion Sickness Treatment Market by Distribution Channel

Chapter 7. Company Profiles

• 7.1 Viatris, Inc.
  • 7.1.1 Company Overview
  • 7.1.2 Financial Analysis
  • 7.1.3 Segmental Analysis
  • 7.1.4 Research & Development Expense
• 7.2 Teva Pharmaceutical Industries Ltd.
  • 7.2.1 Company Overview
  • 7.2.2 Financial Analysis
  • 7.2.3 Regional Analysis
  • 7.2.4 Research & Development Expenses
• 7.3 Amneal Pharmaceuticals, Inc.
  • 7.3.1 Company Overview
  • 7.3.2 Financial Analysis
  • 7.3.3 Segmental Analysis
  • 7.3.4 Research & Development Expenses
• 7.4 Baxter International, Inc.
  • 7.4.1 Company Overview
  • 7.4.2 Financial Analysis
  • 7.4.3 Segmental Analysis
  • 7.4.4 Research & Development Expense
• 7.5 Novartis AG
  • 7.5.1 Company Overview
  • 7.5.2 Financial Analysis
  • 7.5.3 Segmental and Regional Analysis
  • 7.5.4 Research & Development Expense
• 7.6 Abbott Laboratories
  • 7.6.1 Company Overview
  • 7.6.2 Financial Analysis
  • 7.6.3 Segmental and Regional Analysis
  • 7.6.4 Research & Development Expense
  • 7.6.5 SWOT Analysis
• 7.7 Sun Pharmaceutical Industries Ltd.
  • 7.7.1 Company Overview
  • 7.7.2 Financial Analysis
  • 7.7.3 Regional Analysis
  • 7.7.4 Research & Development Expenses
• 7.8 Zydus Lifesciences Ltd.
  • 7.8.1 Company Overview
  • 7.8.2 Financial Analysis
  • 7.8.3 Segmental and Regional Analysis
  • 7.8.4 Research & Development Expense
  • 7.8.5 Recent strategies and developments:
    • 7.8.5.1 Trials and Approvals:
• 7.9 Prestige Consumer Healthcare, Inc.
  • 7.9.1 Company Overview
  • 7.9.2 Financial Analysis
  • 7.9.3 Segmental and Regional Analysis
• 7.10. WellSpring Pharmaceutical Corporation (Avista Capital Partners)
  • 7.10.1 Company Overview